Full Text View
Tabular View
Study Results
Related Studies
Study to Compare the Efficacy and Safety of DenosumAb Versus Placebo in Males With Osteoporosis
This study has been completed.
Study NCT00980174   Information provided by Amgen

First Received on September 17, 2009.   Last Updated on January 22, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Low Bone Mass
Low Bone Mineral Density
Males With Osteoporosis
Osteopenia
Osteoporosis
Additional conditions recognized in this trial
Bone Diseases, Metabolic
More general conditions related to this trial
Bone Diseases
Musculoskeletal Diseases
Interventions listed in this trial
60 mg denosumab
Placebo
Sponsors listed in this trial
Amgen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services